Aquestive Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
607
across all filing types
Latest filing
2026-04-24
Annual Report
Country
US
United States of America
Listing
US
AQST
Aquestive Therapeutics is a pharmaceutical company that develops and commercializes medicines using its proprietary PharmFilm® technology. This oral film drug delivery system provides a non-invasive and convenient alternative to conventional therapies, such as injections, by enabling the oral administration of complex molecules. The company's development pipeline is focused on addressing unmet medical needs in central nervous system (CNS) disorders and severe allergic reactions. Key product candidates include Anaphylm™, an epinephrine sublingual film for the emergency treatment of anaphylaxis, and Libervant®, a diazepam buccal film for the management of seizure clusters.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Aquestive Therapeutics, Inc. (0001398733) (Filer) | 2026-04-24 | English | |
| 8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer) | 2026-03-30 | English | |
| 8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer) | 2026-03-20 | English | |
| 8-K - AQUESTIVE THERAPEUTICS, INC. (0001398733) (Filer) | 2026-02-26 | English | |
| 8-K Filing | 2026-02-02 | English | |
| S-8 Filing | 2026-01-21 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 36284087 | ARS - Aquestive Therapeutics, Inc. (0001398733) (Filer) | 2026-04-24 | English | ||
| 33087643 | 8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer) | 2026-03-30 | English | ||
| 32998634 | 8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer) | 2026-03-20 | English | ||
| 32891257 | 8-K - AQUESTIVE THERAPEUTICS, INC. (0001398733) (Filer) | 2026-02-26 | English | ||
| 29399870 | 8-K Filing | 2026-02-02 | English | ||
| 29399868 | S-8 Filing | 2026-01-21 | English | ||
| 29399871 | 8-K Filing | 2026-01-09 | English | ||
|
2025
8 filings
| |||||
| 12149379 | PRIMARY DOCUMENT | 2025-12-05 | English | ||
| 12149382 | PRIMARY DOCUMENT | 2025-12-04 | English | ||
| 12149383 | Regulatory Filings 2025 | 2025-11-17 | English | ||
| 12149386 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12149384 | PRIMARY DOCUMENT | 2025-11-12 | English | ||
| 12149397 | PRIMARY DOCUMENT | 2025-11-12 | English | ||
| 12149387 | 8-K | 2025-11-06 | English | ||
| 12149396 | 10-Q | 2025-11-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Aquestive Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32552/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32552 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32552 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32552 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32552}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aquestive Therapeutics, Inc. (id: 32552)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.